Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 9 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
81 37.0 months NHL 4 Chemotherapy
Tianjin Medical University Cancer Institute and Hospital China 3/2015
Treatment Details: Patients: This study involved 49 refractory or relapsed T-Cell lymphoma patients. The median patient age was 50 years and 61.2% were male. Treatment: Patients received chemotherapy wit
 
82 36.6 months Metastatic Breast Cancer 4 Chemotherapy
LinKo Chang Gung Memorial Hospital Taiwan Region 5/2015
Treatment Details: Patients: This phase 2 study involved 45 female metastatic breast cancer patients who had received previous taxane-based chemotherapy. The median patient age was 52.5 years. Treatment:
 
83 36.6 months Ovarian cancer 5 Biologic therapy
Chemotherapy
St. James's University Hospital United Kingdom 12/2011
Treatment Details: Patients: This phase 3 study involved women with ovarian cancer who were divided into 2 separate treatment groups. Group A consisted of 764 patients with a median age of 57 years (range of
 
84 36.4 months metastatic breast cancer 5 Chemotherapy
Morgagni-Pierantoni Hospital Italy 3/2006
Treatment Details: Patients: This Phase II study involved 33 women with advanced or metastatic (stage IIIB-IV) breast cancer. The median age was 59, and most participants were postmenopausal. Treatment:
 
85 36.0 months Metastatic colorectal cancer and Liver metastases 4 Chemotherapy
Centre Régional de Lutte contre le Cancer Val d'Aurelle France 7/2008
Treatment Details: Patients: This phase 2 study involved 34 metastatic colorectal cancer patients who had metastases to the liver. The median patient age was 58 years and 64.7% were male. Treatment: Pati
 
86 35.7 months Advanced breast cancer 5 Biologic therapy
Chemotherapy
Rigshospitalet Denmark 1/2011
Treatment Details: Patients: This phase 3 study involved women with advanced breast cancer (genetically HER2-positive) who were divided into two separate treatment groups. Group A consisted of 143 patients w
 
87 35.7 months Metastatic or advanced breast cancer 4 Chemotherapy
Hotel-Dieu de France University Hospital Lebanon 6/2008
Treatment Details: Patients: This phase II study involved 40 women with advanced or metastatic breast cancer. The median age was 57 years, ranging from 36 to 80. The majority (75%) had been previously treate
 
88 35.6 months metastatic breast cancer 5 Chemotherapy
Radiation
Duke University Medical Center United States 6/2006
Treatment Details: Patients: This Phase III trial involved a total 85 patients of which 69 were randomized to one of two groups. Group A had 35 women and Group B had 34 women. In both groups the average age
 
89 35.6 months Metastatic breast cancer 5 Biologic therapy
Chemotherapy
University of Munich Germany 8/2010
Treatment Details: Patients: This phase II study involved 42 women with HER2-overexpressing metastatic breast cancer. The median age was 60 years, with a range of 34-75. Treatment: Patients were treated
 
90 35.3 months Epithelial ovarian cancer 3 Chemotherapy
University Hospital, Örebro Sweden 1/2013
Treatment Details: Patients: This study involved 108 epithelial ovarian cancer patients who had not received prior radiation therapy or chemotherapy. The average patient age was 63.3 years. Treatment: Pat
 
Page 9 of 187  | Previous Page  | Next Page